Arquivamento definitivo - Art. 33 da LPI
#11.1.1
05/24/2022
RPI 2681
Application data
Number
112020010632Type
Filing
Publication
PCT
EP2018082634 The application was abandoned: examination was not requested within the 36 months following the 11/27/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/24/2022. We update with every new RPI gazette, published weekly.
Applicants
BALIOPHARM AG
CH
Inventors
A. H. (pessoa física)
CH
H. B. (pessoa física)
DE
K. P. (pessoa física)
DE
IPC Classification
Priority claims
EP
17203853.1 · 11/27/2017
Abstract
ANTICORPOS QUE RECONHECEM ESPECIFICAMENTE O FATOR DE NECROSE TUMORAL 1 HUMANO (huTNFR1) E SEU USO MÉDICO. A invenção se refere a anticorpos que reconhecem especificamente o fator de necrose tumoral 1 humano (huTNFR1), para uso no tratamento de esteato-hepatite não alcoólica (NASH) e condições de doença associadas a ela.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
05/24/2022
RPI 2681
#11.1
03/08/2022
RPI 2670
#15.35
12/07/2021
RPI 2657
#1.3
11/10/2020
RPI 2601
#1.1
10/06/2020
RPI 2596
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.